Gopinatth Varun, Tartibi Sina, Smith Matthew V, Matava Matthew J, Brophy Robert H, Knapik Derrick M
Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Department of Orthopaedic Surgery, Washington University School of Medicine, Saint Louis, Missouri, USA.
Orthop J Sports Med. 2025 Apr 16;13(4):23259671251330307. doi: 10.1177/23259671251330307. eCollection 2025 Apr.
Bone-patellar tendon-bone (BTB) and hamstring tendon (HT) autografts are the most commonly utilized grafts for primary anterior cruciate ligament reconstruction (ACLR). While previous studies have compared outcomes using BTB and HT grafts for ACLR at short- and mid-term follow-ups, outcomes at long-term follow-ups remain unclear.
To perform a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating BTB versus HT autografts for primary ACLR at a minimum 10-year follow-up.
Systematic review; Level of evidence, 2.
A systematic review was performed in accordance with the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines by querying 5 databases from inception through May 2024 to identify level 1 and 2 RCTs evaluating outcomes of BTB versus HT autografts for primary ACLR at a minimum 10-year follow-up. A meta-analysis was performed using random-effects models with risk ratios (RRs) for discrete outcomes and mean differences (MDs) for continuous outcomes.
Six RCTs-consisting of 495 (BTB, n = 235; HT, n = 260) patients-were identified. The mean age at the follow-up was 41.3 ± 7.4 years, with men comprising 64% (n = 316/495) of patients. The mean final follow-up time was 14.6 ± 0.7 years (range, 10-17 years). No significant differences were observed in ACL graft rupture or revision rates (RR, 0.88; = .70), contralateral ACL rupture rates (RR, 1.27; = .46), Lysholm scores (MD, -1.27; = .45), Tegner scores (MD, -0.01; = .97), extension deficits (RR, 2.67; = .23), or KT-1000 side-to-side differences (MD, -0.56; = .10). There was a significantly greater risk of osteoarthritis (OA) progression in ACLR knees compared with the contralateral knee (RR, 3.64; < .0001); however, there was no difference in OA progression between BTB and HT groups (RR, 1.01; = .91).
BTB and HT autografts for primary ACLR demonstrate similar outcomes and rates of OA progression at long-term follow-ups. Knees undergoing ACLR have a greater risk of OA progression compared with healthy contralateral knees.
骨-髌腱-骨(BTB)和腘绳肌腱(HT)自体移植物是初次前交叉韧带重建(ACLR)中最常用的移植物。虽然既往研究比较了BTB和HT移植物用于ACLR在短期和中期随访时的结果,但长期随访的结果仍不明确。
对评估BTB与HT自体移植物用于初次ACLR且至少随访10年的随机对照试验(RCT)进行系统评价和荟萃分析。
系统评价;证据等级,2级。
按照2020年PRISMA(系统评价和荟萃分析的首选报告项目)指南进行系统评价,通过检索5个数据库,从建库至2024年5月,以识别评估BTB与HT自体移植物用于初次ACLR且至少随访10年的1级和2级RCT。使用随机效应模型进行荟萃分析,对于离散结局采用风险比(RR),对于连续结局采用平均差(MD)。
确定了6项RCT,共495例患者(BTB组,n = 235;HT组,n = 260)。随访时的平均年龄为41.3±7.4岁,男性占患者的64%(n = 316/495)。平均最终随访时间为14.6±0.7年(范围,10 - 17年)。在ACLR移植物破裂或翻修率(RR,0.88;P = 0.70)、对侧ACLR破裂率(RR,1.27;P = 0.46)、Lysholm评分(MD, - 1.27;P = 0.45)、Tegner评分(MD, - 0.01;P = 0.97)、伸展受限(RR,2.67;P = 0.23)或KT - 1000两侧差值(MD, - 0.56;P = 0.10)方面未观察到显著差异。与对侧膝关节相比,ACLR膝关节发生骨关节炎(OA)进展的风险显著更高(RR,3.64;P < 0.0001);然而,BTB组和HT组之间在OA进展方面无差异(RR,1.01;P = 0.91)。
用于初次ACLR的BTB和HT自体移植物在长期随访中显示出相似的结果和OA进展率。与健康的对侧膝关节相比,接受ACLR的膝关节发生OA进展的风险更高。